Trastuzumab deruxtecan Active Not Recruiting Phase 2 Trials for Adenocarcinoma Gastric Stage IV With Metastases / Adenocarcinoma - GEJ Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04014075DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)